Cart 2

Labetuzumab govitecan (Synonyms: ANTI-CEACAM5-SN 38)

Cat.#: 177173

Size:

Special Price 301.5 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Labetuzumab govitecan (Synonyms: ANTI-CEACAM5-SN 38)
  • Documents
  • Description
    Anti-CEACAM5 / CEA / CD66e Antibody (Labetuzumab govitecan)
  • Tested applications
    ELISA
  • Species reactivity
    Human CEACAM5 / CEA / CD66e
  • Alternative names
    ANTI-CEACAM5-SN 38 antibody
  • Isotype
    IgG1
  • Preparation
    Recombinant expression and purified from CHO cells.
  • Clonality
    Monoclonal
  • Formulation
    0.1 M Pro-Ac, 20 mM Arg, pH 5.0
  • Storage instructions
    -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
  • Validations

    SEC-HPLC

    SEC-HPLC

    The purity of Anti-CEACAM5 / CEA / CD66e Antibody (labetuzumab govitecan) is 95%, determined by SEC-HPLC.

    HIC-HPLC

    HIC-HPLC

    The drug-to-antibody ratio (DAR) of theAnti-CEACAM5 / CEA / CD66e Antibody (labetuzumab govitecan) is 8.0.

    Bioactivity: FACS

    Bioactivity: FACS

    Human CEACAM5 / CEA / CD66e HEK293 Cell Line were stained Anti-CEACAM5 / CEA / CD66e Antibody (labetuzumab govitecan) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 1.45 ug/mL.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"